Using their knowledge of the gut microbiome and expertise in engineering biology and fermentation, CHAIN Biotechnology develops superior live biotherapeutics. Some of this work is carried out with the help of Whitley Workstations.
In this video, Senior Scientist Dr David Kirk, outlines how his laboratory uses Whitley Workstations to create Clostridium-assisted drug delivery platforms in a bid to counter Inflammatory Bowel Disease caused by dysbiosis of the human gut microbiome.
Click here to watch the video youtu.be/4vrG1sRQihk
